347 related articles for article (PubMed ID: 6321949)
21. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors.
Harden TK; Evans T; Hepler JR; Hughes AR; Martin MW; Meeker RB; Smith MM; Tanner LI
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():207-20. PubMed ID: 2988297
[TBL] [Abstract][Full Text] [Related]
22. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
23. Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesterase.
Sullivan TA; Duemler BH; Kuttesch NJ; Keravis TM; Wells JN
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):355-64. PubMed ID: 2442214
[TBL] [Abstract][Full Text] [Related]
24. Cholinergic inhibition of catecholamine-stimulable cyclic AMP accumulation in murine atria.
Brown JH
J Cyclic Nucleotide Res; 1979 Dec; 5(6):423-33. PubMed ID: 231610
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of the effects of sodium nitroprusside and of isoproterenol by selective phosphodiesterase inhibitors.
Lorenz KL; Wells JN
Mol Pharmacol; 1983 Mar; 23(2):424-30. PubMed ID: 6300651
[TBL] [Abstract][Full Text] [Related]
26. Relative contribution of phosphoinositides and phosphatidylcholine hydrolysis to the actions of carbamylcholine, thyrotropin (TSH), and phorbol esters on dog thyroid slices: regulation of cytidine monophosphate-phosphatidic acid accumulation and phospholipase-D activity. I. Actions of carbamylcholine, calcium ionophores, and TSH.
Lejeune C; Mockel J; Dumont JE
Endocrinology; 1994 Dec; 135(6):2488-96. PubMed ID: 7988436
[TBL] [Abstract][Full Text] [Related]
27. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ
J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390
[TBL] [Abstract][Full Text] [Related]
28. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
Chan SC; Hanifin JM
J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
[TBL] [Abstract][Full Text] [Related]
29. Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells.
Meskini N; Hosni M; Nemoz G; Lagarde M; Prigent AF
J Cell Physiol; 1992 Jan; 150(1):140-8. PubMed ID: 1309823
[TBL] [Abstract][Full Text] [Related]
30. Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroid.
Dumont JE; Miot F; Erneux C; Couchie D; Cochaux P; Gervy-Decoster C; Van Sande J; Wells JN
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():325-36. PubMed ID: 6202125
[No Abstract] [Full Text] [Related]
31. Rat pancreatic adenylate cyclase. IV. Effect of hormones and other agents on cyclic AMP level and enzyme release.
Kempen JM; De Pont JJ; Bonting SL
Biochim Biophys Acta; 1977 Jan; 496(1):65-76. PubMed ID: 189833
[TBL] [Abstract][Full Text] [Related]
32. Effects of thyrotropin, carbachol, and protein kinase-C stimulators on glucose transport and glucose oxidation by primary cultures of dog thyroid cells.
Haraguchi K; Rani CS; Field JB
Endocrinology; 1988 Sep; 123(3):1288-95. PubMed ID: 2456912
[TBL] [Abstract][Full Text] [Related]
33. Activation of rat parotid low Km cyclic AMP phosphodiesterase by isoproterenol.
Teo TS; Lee MK; Thiyagarajah P
Biochem Int; 1987 Feb; 14(2):327-36. PubMed ID: 3034281
[TBL] [Abstract][Full Text] [Related]
34. Cooling enhances adenosine 3':5' monophosphate accumulation in thyrotropin stimulated dog thyroid slices.
Delbeke D; Van Sande J; Swillens S; Erneux C; Dumont JE
Metabolism; 1982 Aug; 31(8):797-804. PubMed ID: 6285124
[TBL] [Abstract][Full Text] [Related]
35. Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
Champion S; Mauchamp J
Mol Pharmacol; 1982 Jan; 21(1):66-72. PubMed ID: 6290866
[TBL] [Abstract][Full Text] [Related]
36. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE
Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820
[TBL] [Abstract][Full Text] [Related]
37. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
Mushlin P; Boerth RC; Wells JN
Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
[No Abstract] [Full Text] [Related]
38. Bronchodilator activity of a nonxanthine phosphodiesterase inhibitor; 2,4-diamino-5-cyano-6-bromopyridine (compound I).
Smith PF; Thompson WJ; de Haën C; Halonen M; Palmer JD; Johnson DG
J Pharmacol Exp Ther; 1986 Apr; 237(1):114-9. PubMed ID: 2420965
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of fibroblast cyclic AMP escape and cyclic nucleotide phosphodiesterase activities by xanthines.
Nemecek GM; Wells JN; Butcher RW
Mol Pharmacol; 1980 Jul; 18(1):57-64. PubMed ID: 6251359
[No Abstract] [Full Text] [Related]
40. Islet-activating protein discriminates between different inhibitors of thyroidal cyclic AMP system.
Cochaux P; Van Sande J; Dumont JE
FEBS Lett; 1985 Jan; 179(2):303-6. PubMed ID: 2981707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
